Standard Operating Procedure for Handling Market Complaints Related to Gel Products in Gel Manufacturing
| Department | Gel Manufacturing |
|---|---|
| SOP No. | SOP/GM/117/2025 |
| Supersedes | SOP/GM/117/2022 |
| Page No. | Page 1 of 12 |
| Issue Date | 02/06/2025 |
| Effective Date | 04/06/2025 |
| Review Date | 02/06/2027 |
1. Purpose
To define the procedure for handling, investigating, and responding to market complaints related to gel-based pharmaceutical products.
2. Scope
This procedure applies to all market complaints received for gel formulations manufactured at the facility, whether received directly from customers,
healthcare professionals, or regulatory authorities.
3. Responsibilities
- QA Department: Receives complaints, coordinates investigations, and ensures timely closure.
- Production Head: Supports technical investigation and implements corrective actions if manufacturing-related.
- QC Department: Performs analytical review or re-testing of retained samples.
- Regulatory Affairs: Notifies regulatory agencies if required.
4. Accountability
Head – Quality Assurance
5. Procedure
5.1 Receipt of Complaint
- QA shall receive complaints through phone, email, written communication, or online reporting.
- Log complaint details in the Complaint Register within 24 hours of receipt.
- Assign a unique Complaint Reference Number (CRN).
5.2 Initial Assessment
- Determine if the complaint is quality-related, adverse event-related, or logistical.
- For quality complaints, proceed with a formal investigation.
5.3 Investigation
- Review batch manufacturing records, in-process control results, and final QC data.
- Retrieve and analyze retention samples where applicable.
- Involve cross-functional teams as necessary to trace root cause.
5.4 Categorization of Complaint
- Critical: Product defect with safety risk (e.g., microbial contamination, mislabeling).
- Major: Quality non-conformance affecting performance or stability.
- Minor: Cosmetic or packaging defects with no product impact.
5.5 Corrective and Preventive Action (CAPA)
- Define appropriate CAPA based on investigation findings.
- Record CAPA in the CAPA register and link it to the complaint file.
- Monitor effectiveness of CAPA over a defined timeline.
5.6 Closure and Response
- Compile investigation findings and CAPA summary.
- Communicate response to the complainant within 30 working days.
- Archive complaint file with related batch and CAPA documents.
5.7 Regulatory Reporting
- If complaint involves adverse event or reportable defect, inform regulatory bodies as per pharmacovigilance norms.
6. Abbreviations
- QA: Quality Assurance
- QC: Quality Control
- CAPA: Corrective and Preventive Action
- CRN: Complaint Reference Number
7. Documents
- Complaint Record Form – Annexure-1
- CAPA Log Sheet – Annexure-2
- Complaint Register – Annexure-3
8. References
- WHO TRS 986 Annex 2: GMP Guidelines for Complaints and Product Recalls
- 21 CFR 211.198: Complaint Files (USFDA)
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | Jr. Production Chemist | QA Executive | Head – Manufacturing |
| Department | Gel Manufacturing | Quality Assurance | Manufacturing |
11. Annexures
Annexure-1: Complaint Record Form
| Complaint Reference No. | |
|---|---|
| Date Received | |
| Complainant Details | |
| Product Name | |
| Batch No. | |
| Nature of Complaint | |
| Initial Assessment | |
| Investigation Summary | |
| CAPA Taken | |
| Date of Response | |
| Signature (QA) |
Annexure-2: CAPA Log Sheet
| CAPA No. | Related Complaint Ref. No. | Action Description | Target Date | Status | Remarks |
|---|---|---|---|---|---|
Annexure-3: Complaint Register Format
| CRN | Date | Product | Batch No. | Complaint Type | Status | Closure Date |
|---|---|---|---|---|---|---|
Revision History
| Revision Date | Revision No. | Change Description | Reason | Approved By |
|---|---|---|---|---|
| 21/09/2022 | 1.0 | Initial issue | New SOP | QA Head |
| 02/06/2025 | 2.0 | Added regulatory reporting section, updated annexures | Annual review | QA Head |